Jonathan Gillis

CIK: 0001709954

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)14 (73.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (21.1%)

Compensation grants

Other (G, F, J, C, D, …)1 (5.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

MPLT

MapLight Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (19 total)

MPLT
MapLight Therapeutics, Inc.
Oct 15, 2026
Sale(S)
Direct
10.2K shares at avg. $8.08$82K
MPLT
MapLight Therapeutics, Inc.
Aug 17, 2026
Award(A)
Direct
6K shares-
MPLT
MapLight Therapeutics, Inc.
Aug 17, 2026
Award(A)
Direct
2.2K shares-
MPLT
MapLight Therapeutics, Inc.
Jul 17, 2026
Sale(S)
Direct
900 shares at avg. $38.17$34K
MPLT
MapLight Therapeutics, Inc.
Jul 17, 2026
Sale(S)
Direct
600 shares at avg. $36.51$22K
MPLT
MapLight Therapeutics, Inc.
Jul 17, 2026
Sale(S)
Direct
17K shares at avg. $37.61$638K
MPLT
MapLight Therapeutics, Inc.
Jul 16, 2026
Sale(S)
Direct
1.5K shares at avg. $37.44$55K
MPLT
MapLight Therapeutics, Inc.
Jul 16, 2026
Sale(S)
Direct
7K shares at avg. $36.66$256K
MPLT
MapLight Therapeutics, Inc.
Jul 15, 2026
Sale(S)
Direct
4.7K shares at avg. $36.94$174K
MPLT
MapLight Therapeutics, Inc.
Jul 15, 2026
Sale(S)
Direct
5.4K shares at avg. $36.13$194K
MPLT
MapLight Therapeutics, Inc.
Apr 28, 2026
Sale(S)
Direct
700 shares at avg. $30.83$22K
MPLT
MapLight Therapeutics, Inc.
Apr 28, 2026
Sale(S)
Direct
17.2K shares at avg. $30.33$523K
MPLT
MapLight Therapeutics, Inc.
Apr 27, 2026
Sale(S)
Direct
14.4K shares at avg. $30.46$437K
MPLT
MapLight Therapeutics, Inc.
Apr 27, 2026
Sale(S)
Direct
7.9K shares at avg. $28.94$229K
MPLT
MapLight Therapeutics, Inc.
Apr 27, 2026
Sale(S)
Direct
29.6K shares at avg. $29.60$877K
MPLT
MapLight Therapeutics, Inc.
Apr 15, 2026
Sale(S)
Direct
3.6K shares at avg. $26.61$96K
MPLT
MapLight Therapeutics, Inc.
Feb 5, 2026
Award(A)
Direct
6K shares-
MPLT
MapLight Therapeutics, Inc.
Jan 27, 2026
Tax Payment(F)
Direct
22.1K shares at avg. $17.98$396K
MPLT
MapLight Therapeutics, Inc.
Oct 27, 2025
Award(A)
Direct
30.6K shares-

		Type	Shares	Price		Ownership
Oct 15, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	10,167	$8.08	$82,149	Direct
Aug 17, 2026	MPLT MapLight Therapeutics, Inc.	Award(A)	6,020	-	$0	Direct
Aug 17, 2026	MPLT MapLight Therapeutics, Inc.	Award(A)	2,222	-	$0	Direct
Jul 17, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	900	$38.17	$34,353	Direct
Jul 17, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	600	$36.51	$21,906	Direct
Jul 17, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	16,969	$37.61	$638,204	Direct
Jul 16, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	1,476	$37.44	$55,261	Direct
Jul 16, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	6,979	$36.66	$255,850	Direct
Jul 15, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	4,699	$36.94	$173,581	Direct
Jul 15, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	5,356	$36.13	$193,512	Direct
Apr 28, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	700	$30.83	$21,581	Direct
Apr 28, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	17,235	$30.33	$522,738	Direct
Apr 27, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	14,363	$30.46	$437,497	Direct
Apr 27, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	7,914	$28.94	$229,031	Direct
Apr 27, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	29,623	$29.60	$876,841	Direct
Apr 15, 2026	MPLT MapLight Therapeutics, Inc.	Sale(S)	3,590	$26.61	$95,530	Direct
Feb 5, 2026	MPLT MapLight Therapeutics, Inc.	Award(A)	6,020	-	$0	Direct
Jan 27, 2026	MPLT MapLight Therapeutics, Inc.	Tax Payment(F)	22,050	$17.98	$396,459	Direct
Oct 27, 2025	MPLT MapLight Therapeutics, Inc.	Award(A)	30,565	-	-	Direct

1-19 of 19 transactions

About GILLIS JONATHAN

GILLIS JONATHAN (SEC CIK 0001709954) files insider reports with the SEC as CAO and Interim CFO of MapLight Therapeutics, Inc. (MPLT).

Signal8 holds 9 ownership filings by GILLIS JONATHAN (1 Form 3, 8 Form 4), filed between Oct 27, 2025 and Oct 16, 2026. Those filings report 19 transactions, from Oct 27, 2025 to Oct 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on GILLIS JONATHAN's filings is in REDWOOD CITY, CA.

Recent filings by GILLIS JONATHAN

Oct 15, 2026: Open-market sale of MPLT shares (Form 4, code S).
Aug 17, 2026: Grants or awards of MPLT shares (2 lines, Form 4, code A).
Jul 17, 2026: Open-market sales of MPLT shares (3 lines, Form 4, code S).
Jul 16, 2026: Open-market sales of MPLT shares (2 lines, Form 4, code S).
Jul 15, 2026: Open-market sales of MPLT shares (2 lines, Form 4, code S).

Other insiders filing for MapLight Therapeutics, Inc. (MPLT)

Kreitzer Anatol, Chief Discovery Officer
Lillie James Woodruff, Chief Scientific Officer
Hanson Kristopher, General Counsel
Foff Erin Pennock, Chief Medical Officer
Kroeger Christopher A., Chief Executive Officer
Cox Troy, Director

How to read Form 4 transaction codes